5/11/23 16:11 | 5/10/23 | ESPR | Health | Drug | Pharmaceutical Preparations | Carroll J Martin | MI | D | | P.m | 49 | 1.55 | 0 | 32 | 630 | 37 | D | | | | | | | | | | | | | | |
5/11/23 16:10 | 5/10/23 | ESPR | Health | Drug | Pharmaceutical Preparations | Rocamboli Stephen | MI | D | | P | 12 | 1.50 | 0 | 8 | New | 8 | D | | | | | | | | | | | | | | |
5/10/23 16:12 | 5/9/23 | ESPR | Health | Drug | Pharmaceutical Preparations | Koenig Sheldon L. | MI | DO | P,CEO | P | 25 | 1.26 | 0 | 20 | 7 | 313 | D | | | | | | | | | | | | | | |
8/31/22 16:14 | 8/31/22 | ESPR | Health | Drug | Pharmaceutical Preparations | Warren Eric | MI | O | Chief Co | P | 7 | 7.46 | 0 | 1 | 2 | 54 | D | | | | | | | | | | | | | | |
8/8/22 16:14 | 8/5/22 | ESPR | Health | Drug | Pharmaceutical Preparations | Koenig Sheldon L. | MI | DO | P,CEO | P | 50 | 5.80 | 0 | 9 | 5 | 199 | D | | | | | | | | | | | | | | |
6/3/22 16:11 | 6/2/22 | ESPR | Health | Drug | Pharmaceutical Preparations | Carroll J Martin | MI | D | | P | 28 | 5.64 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
5/26/21 11:53 | 5/24/21 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,022 | 20.22 | 0 | 100 | 2 | 4,478 | D | | | | | | | | | | | | | | |
5/21/21 14:06 | 5/19/21 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 4,074 | 20.37 | 0 | 200 | 5 | 4,378 | D | | | | | | | | | | | | | | |
5/7/21 15:23 | 5/5/21 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P.m | 4,648 | 20.21 | 0 | 230 | 6 | 4,178 | D | | | | | | | | | | | | | | |
11/4/20 16:37 | 11/3/20 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 5,062 | 25.31 | 0 | 200 | 5 | 3,948 | D | | | | | | | | | | | | | | |
3/12/20 07:34 | 3/11/20 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 108 | 43.00 | 0 | 3 | 2 | 112 | D | | | | | | | | | | | | | | |
3/2/20 06:16 | 2/28/20 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 245 | 49.00 | 0 | 5 | 5 | 109 | D | | | | | | | | | | | | | | |
1/27/20 12:51 | 1/23/20 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 1,042 | 52.12 | 0 | 20 | 1 | 3,748 | D | | | | | | | | | | | | | | |
11/8/19 16:14 | 11/6/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 185 | 36.98 | 0 | 5 | 6 | 84 | D | | | | | | | | | | | | | | |
11/8/19 14:54 | 11/6/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,798 | 37.30 | 0 | 75 | 2 | 3,728 | D | | | | | | | | | | | | | | |
9/6/19 16:22 | 9/4/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P.m | 259 | 34.55 | 0 | 8 | 11 | 79 | D | | | | | | | | | | | | | | |
9/6/19 16:09 | 9/4/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,702 | 33.78 | 0 | 80 | 2 | 3,653 | D | | | | | | | | | | | | | | |
8/2/19 16:06 | 8/1/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 198 | 39.56 | 0 | 5 | 8 | 71 | D | | | | | | | | | | | | | | |
7/25/19 12:42 | 7/23/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,133 | 42.65 | 0 | 50 | 1 | 3,573 | D | | | | | | | | | | | | | | |
7/1/19 16:57 | 6/28/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 230 | 46.00 | 0 | 5 | 8 | 66 | D | | | | | | | | | | | | | | |
4/1/19 16:41 | 3/29/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 200 | 40.00 | 0 | 5 | 9 | 61 | D | | | | | | | | | | | | | | |
3/21/19 17:01 | 3/20/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 217 | 43.48 | 0 | 5 | 10 | 56 | D | | | | | | | | | | | | | | |
3/15/19 19:50 | 3/14/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,494 | 49.89 | 0 | 50 | 1 | 3,523 | D | | | | | | | | | | | | | | |
3/14/19 16:57 | 3/14/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 244 | 48.73 | 0 | 5 | 11 | 51 | D | | | | | | | | | | | | | | |
1/7/19 17:10 | 1/4/19 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 3,303 | 41.29 | 0 | 80 | 2 | 3,473 | D | | | | | | | | | | | | | | |
12/26/18 11:44 | 12/24/18 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 1,996 | 39.91 | 0 | 50 | 1 | 3,393 | D | | | | | | | | | | | | | | |
12/19/18 13:14 | 12/17/18 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,864 | 47.73 | 0 | 60 | 2 | 3,343 | D | | | | | | | | | | | | | | |
8/6/18 15:23 | 8/3/18 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,307 | 46.14 | 0 | 50 | 2 | 3,283 | D | | | | | | | | | | | | | | |
7/13/18 11:45 | 7/12/18 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,088 | 41.77 | 0 | 50 | 2 | 3,233 | D | | | | | | | | | | | | | | |
7/3/18 11:55 | 6/29/18 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 1,974 | 39.48 | 0 | 50 | 2 | 3,183 | D | | | | | | | | | | | | | | |
6/25/18 12:43 | 6/21/18 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,314 | 38.57 | 0 | 60 | 2 | 3,133 | D | | | | | | | | | | | | | | |
6/11/18 14:59 | 6/7/18 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,267 | 37.79 | 0 | 60 | 2 | 3,073 | D | | | | | | | | | | | | | | |
6/7/18 14:34 | 6/5/18 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,308 | 38.47 | 0 | 60 | 2 | 3,013 | D | | | | | | | | | | | | | | |
5/22/18 15:49 | 5/18/18 | ESPR | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P.m | 5,214 | 40.11 | 0 | 130 | 5 | 2,953 | D | | | | | | | | | | | | | | |
3/22/17 08:02 | 3/21/17 | ESPR | Health | Drug | Pharmaceutical Preparations | Omenn Gilbert S | MI | D | | P | 42 | 42.26 | 33 | 1 | 10 | 11 | I | -65 | 138 | 241 | 201 | 94 | 28 | 26 | 32 | 0 | -9 | -4 | | | |
11/3/16 17:58 | 11/1/16 | ESPR | Health | Drug | Pharmaceutical Preparations | Lalwani Narendra D. | MI | O | COO | P | 50 | 9.93 | 4 | 5 | New | 5 | D | -65 | -63 | -29 | -7 | -27 | -22 | -16 | -8 | 5 | 13 | 16 | 69 | 252 | |
7/7/16 07:17 | 7/5/16 | ESPR | Health | Drug | Pharmaceutical Preparations | McGovern Mark E | MI | D | | P.m | 50 | 10.00 | 10 | 5 | New | 5 | D | -32 | -89 | -53 | -47 | -33 | -40 | -36 | 4 | 3 | 4 | 7 | 33 | 35 | |
5/5/16 07:33 | 5/4/16 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 104 | 14.85 | 5 | 7 | 20 | 42 | D | 10 | -85 | -46 | -6 | -2 | -22 | -21 | -12 | 0 | 4 | 18 | -22 | -29 | |
3/2/16 07:23 | 3/1/16 | ESPR | Health | Drug | Pharmaceutical Preparations | Omenn Gilbert S | MI | D | | P | 76 | 15.28 | 7 | 5 | 100 | 10 | D | 0 | -75 | -70 | -46 | 15 | 9 | -6 | 4 | 17 | 2 | 9 | 10 | -31 | 96 |
1/28/16 18:22 | 1/27/16 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 57 | 15.88 | 12 | 4 | 12 | 35 | D | -3 | -69 | -79 | -38 | -38 | -28 | 6 | -22 | 7 | 9 | 11 | 22 | -18 | -16 |
1/19/16 07:16 | 1/15/16 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 101 | 14.08 | 13 | 7 | 30 | 31 | D | -8 | -68 | -86 | -44 | -49 | -41 | -32 | -16 | -2 | 21 | 21 | 38 | -17 | -19 |
10/21/14 19:33 | 10/21/14 | ESPR | Health | Drug | Pharmaceutical Preparations | Alta Partners Viii, L.P. | CA | T | | P | 10,000 | 20.00 | 12 | 500 | 24 | 2,552 | I | | 28 | 49 | 52 | 47 | -10 | -21 | -5 | 2 | 13 | 44 | 102 | 352 | 0 |
10/21/14 18:53 | 10/21/14 | ESPR | Health | Drug | Pharmaceutical Preparations | Janney Daniel | CA | DT | | P | 10,000 | 20.00 | 12 | 500 | 24 | 2,552 | I | | 28 | 49 | 52 | 47 | -10 | -21 | -5 | 2 | 13 | 44 | 102 | 352 | 0 |
10/21/14 17:31 | 10/21/14 | ESPR | Health | Drug | Pharmaceutical Preparations | Omenn Gilbert S | MI | D | | P | 100 | 20.00 | 12 | 5 | New | 5 | D | | 28 | 49 | 52 | 47 | -10 | -21 | -5 | 2 | 13 | 44 | 102 | 352 | 0 |
10/21/14 12:15 | 10/21/14 | ESPR | Health | Drug | Pharmaceutical Preparations | Domain Parters VII L P | NJ | T | | P | 10,000 | 20.00 | 12 | 500 | 24 | 2,567 | D | | 28 | 49 | 52 | 47 | -10 | -21 | -5 | 3 | 16 | 47 | 106 | 355 | 3 |
7/2/13 17:03 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Blair James C | NJ | T | | P.d | 4,000 | 14.00 | 14 | 286 | 16 | 2,102 | I | | | | | | | | -3 | 0 | 8 | 23 | 31 | -13 | 9 |
7/2/13 17:00 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Dp VII Associates LP | NJ | T | | P.d | 67 | 14.00 | 14 | 5 | 16 | 35 | D | | | | | | | | -3 | 0 | 8 | 23 | 31 | -13 | 9 |
7/2/13 16:55 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Domain Parters VII L P | NJ | T | | P.d | 3,933 | 14.00 | 14 | 281 | 16 | 2,067 | D | | | | | | | | -3 | 0 | 8 | 23 | 31 | -13 | 9 |
7/2/13 16:51 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Halak Brian K | NJ | T | | P.d | 4,000 | 14.00 | 14 | 286 | 16 | 2,102 | I | | | | | | | | -3 | 0 | 8 | 23 | 31 | -13 | 9 |
7/2/13 16:48 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Dovey Brian H | NJ | T | | P.d | 4,000 | 14.00 | 14 | 286 | 16 | 2,102 | I | | | | | | | | -3 | 0 | 8 | 23 | 31 | -13 | 9 |
7/2/13 16:40 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Schoemaker Kathleen K | NJ | T | | P.d | 4,000 | 14.00 | 14 | 286 | 16 | 2,102 | I | | | | | | | | -3 | 0 | 8 | 23 | 31 | -13 | 9 |
7/2/13 16:35 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Treu Jesse I | NJ | T | | P.d | 4,000 | 14.00 | 14 | 286 | 16 | 2,102 | I | | | | | | | | -3 | 0 | 8 | 23 | 31 | -13 | 9 |
7/2/13 16:31 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Vitullo Nicole | NJ | DT | | P.d | 4,000 | 14.00 | 14 | 286 | 16 | 2,102 | I | | | | | | | | -3 | 0 | 8 | 23 | 31 | -13 | 9 |
7/1/13 16:40 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Longitude Capital Partners, LLC | CA | T | | P.d | 3,033 | 14.00 | 18 | 217 | 13 | 1,934 | I | | | | | | | | | 4 | 7 | 26 | 33 | -7 | 13 |
7/1/13 16:39 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | DO | P,CEO | P | 70 | 14.00 | 18 | 5 | 21 | 29 | D | | | | | | | | | 4 | 7 | 26 | 33 | -7 | 13 |
7/1/13 16:38 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Newton Roger S | MI | DO | Exec CB, | P.d | 593 | 14.00 | 18 | 42 | 7 | 630 | D | | | | | | | | | 4 | 7 | 26 | 33 | -7 | 13 |
7/1/13 16:38 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Lange Louis G | MI | D | | P.d | 199 | 14.00 | 18 | 14 | 7 | 216 | M | | | | | | | | | 4 | 7 | 26 | 33 | -7 | 13 |
7/1/13 16:37 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Goldstein Dov A Md | NY | D | | P.d | 3,334 | 14.00 | 18 | 238 | 13 | 2,055 | I | | | | | | | | | 4 | 7 | 26 | 33 | -7 | 13 |
7/1/13 16:36 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Enright Patrick G | CA | DT | | P.d | 3,033 | 14.00 | 18 | 217 | 13 | 1,934 | I | | | | | | | | | 4 | 7 | 26 | 33 | -7 | 13 |
7/1/13 16:34 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Janney Daniel | CA | D | | P.d | 3,300 | 14.00 | 18 | 236 | 13 | 2,052 | I | | | | | | | | | 4 | 7 | 26 | 33 | -7 | 13 |
7/1/13 16:33 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Alta Partners Viii, L.P. | CA | T | | P.d | 3,300 | 14.00 | 18 | 236 | 13 | 2,052 | I | | | | | | | | | 4 | 7 | 26 | 33 | -7 | 13 |
7/1/13 16:33 | 7/1/13 | ESPR | Health | Drug | Pharmaceutical Preparations | Aisling Capital II LP | NY | T | | P.d | 3,334 | 14.00 | 18 | 238 | 13 | 2,055 | I | | | | | | | | | 4 | 7 | 26 | 33 | -7 | 13 |